UNITED STATES COLLABORATION AGREEMENTCollaboration Agreement |
|
|
|
You are currently viewing: This Collaboration Agreement involves
SHIRE PLC | SHIRE PHARMACEUTICALS PLC | NEW RIVER PHARMACEUTICALS INC.. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Collaboration Agreement by:
Exhibit 10.2
*Represents language for which confidential treatment has been requested.
UNITED STATES
COLLABORATION AGREEMENT
BY AND AMONG
SHIRE LLC
SHIRE PHARMACEUTICALS PLC
AND
NEW RIVER PHARMACEUTICALS INC.
DATED AS OF MARCH 31, 2005
|
TABLE OF CONTENTS |
||||
|
|
|
|
|
Page |
|
ARTICLE 1 |
|
DEFINITIONS |
|
2 |
|
ARTICLE 2 |
|
MANAGEMENT OF COLLABORATION |
|
13 |
|
2.1 |
|
General |
|
13 |
|
2.2 |
|
Joint Development Committee (JDC) |
|
13 |
|
2.3 |
|
Joint Marketing Committee (JMC) |
|
14 |
|
2.4 |
|
Joint Supply Committee (JSC) |
|
15 |
|
2.5 |
|
Joint Intellectual Property Committee (JIPC) |
|
17 |
|
2.6 |
|
General Committee Membership and Procedures |
|
17 |
|
2.7 |
|
Committee Decision-Making |
|
18 |
|
ARTICLE 3 |
|
DEVELOPMENT AND REGULATORY RESPONSIBILITIES |
|
20 |
|
3.1 |
|
Overview |
|
20 |
|
3.2 |
|
Development Plans |
|
20 |
|
3.3 |
|
Development in the US Territory for ADHD |
|
21 |
|
3.4 |
|
Right of Reference to the ROW Territory |
|
23 |
|
3.5 |
|
Reporting |
|
23 |
|
3.6 |
|
Development in the US Territory for Indications other than ADHD |
|
23 |
|
3.7 |
|
Shared Expenses |
|
25 |
|
3.8 |
|
Use of Third Parties |
|
26 |
|
3.9 |
|
Right to Audit |
|
27 |
|
3.10 |
|
Assistance |
|
27 |
|
3.11 |
|
Compliance with Laws |
|
27 |
|
ARTICLE 4 |
|
COMMERCIALIZATION OF COLLABORATION PRODUCTS |
|
28 |
|
4.1 |
|
Principles of Commercialization |
|
28 |
|
4.2 |
|
Sales and Distribution of Collaboration Products to Third Parties |
|
28 |
|
4.3 |
|
Marketing Plans and Budgets for the US Territory |
|
28 |
|
4.4 |
|
Regulatory Obligations During Commercialization |
|
29 |
|
4.5 |
|
Diligence in Commercialization |
|
29 |
|
4.6 |
|
Cost of Commercialization |
|
30 |
|
4.7 |
|
Use of Third Parties |
|
30 |
|
|
||||
|
i |
||||
|
TABLE OF CONTENTS |
||||
|
(continued) |
||||
|
|
|
|
|
Page |
|
4.8 |
|
Promotional Materials |
|
30 |
|
4.9 |
|
Provisions Applicable to Sales Representatives |
|
30 |
|
4.10 |
|
Reporting |
|
33 |
|
4.11 |
|
Compliance with Laws |
|
33 |
|
ARTICLE 5 |
|
CO-PROMOTION OF COLLABORATION PRODUCTS |
|
33 |
|
5.1 |
|
Option |
|
34 |
|
5.2 |
|
Exercise of Option |
|
34 |
|
5.3 |
|
Co-Promotion Period |
|
34 |
|
5.4 |
|
Amendment of Marketing Plan to Include Co-Promotion Activities |
|
34 |
|
5.5 |
|
Scope |
|
34 |
|
5.6 |
|
Advertising and Promotional Materials |
|
35 |
|
5.7 |
|
Shipment, Storage and Allocation of Samples |
|
35 |
|
5.8 |
|
Training |
|
35 |
|
5.9 |
|
Provisions Applicable to All New River Sales Representatives |
|
37 |
|
ARTICLE 6 |
|
MANUFACTURE OF COLLABORATION PRODUCTS |
|
36 |
|
6.1 |
|
Manufacture and Supply |
|
36 |
|
6.2 |
|
Specifications and Terms of Supply; Multiple Sources |
|
37 |
|
6.3 |
|
Manufacture by Shire; Commercial Supply by Shire |
|
38 |
|
6.4 |
|
Supply Terms |
|
39 |
|
ARTICLE 7 |
|
FINANCIAL TERMS |
|
39 |
|
7.1 |
|
Licensing Fee |
|
39 |
|
7.2 |
|
Milestone Payments |
|
39 |
|
7.3 |
|
Refunds by New River |
|
40 |
|
7.4 |
|
Sharing of US Product Profit |
|
40 |
|
ARTICLE 8 |
|
PAYMENT TERMS |
|
41 |
|
8.1 |
|
Payment Method |
|
41 |
|
8.2 |
|
Payment Schedules; Reports |
|
41 |
|
8.3 |
|
Currency Conversion |
|
42 |
|
|
||||
|
ii |
||||
|
TABLE OF CONTENTS |
||||
|
(continued) |
||||
|
|
|
|
|
Page |
|
8.4 |
|
Legal Restrictions |
|
42 |
|
8.5 |
|
Taxes |
|
42 |
|
8.6 |
|
Records Retention; Audit |
|
43 |
|
ARTICLE 9 |
|
LICENSES |
|
44 |
|
9.1 |
|
Licenses to Shire |
|
44 |
|
9.2 |
|
Licenses to New River |
|
44 |
|
9.3 |
|
Sublicensing |
|
44 |
|
9.4 |
|
Scope of Licenses |
|
44 |
|
9.5 |
|
No Implied Licenses |
|
44 |
|
9.6 |
|
Exclusivity |
|
45 |
|
9.7 |
|
Nonassertion |
|
45 |
|
9.8 |
|
[*] |
|
45 |
|
ARTICLE 10 |
|
CONFIDENTIALITY |
|
45 |
|
10.1 |
|
Confidential Information |
|
46 |
|
10.2 |
|
Publicity; Filing of this Agreement |
|
47 |
|
10.3 |
|
Publication |
|
48 |
|
10.4 |
|
Use of Names |
|
48 |
|
10.5 |
|
Confidentiality of this Agreement |
|
48 |
|
10.6 |
|
Disclosures Under Existing NDA |
|
48 |
|
10.7 |
|
Survival |
|
49 |
|
ARTICLE 11 |
|
OWNERSHIP OF INTELLECTUAL PROPERTY AND PATENT RIGHTS |
|
49 |
|
11.1 |
|
Ownership |
|
49 |
|
11.2 |
|
Disclosures; Disputes Regarding Inventions |
|
49 |
|
11.3 |
|
Patent Filings |
|
50 |
|
11.4 |
|
Third-Party Patent Rights |
|
51 |
|
11.5 |
|
Enforcement and Defense of Patents |
|
51 |
|
11.6 |
|
Notice of Certification |
|
54 |
iii
|
TABLE OF CONTENTS |
||||||
|
(continued) |
||||||
|
|
|
|
|
|
|
Page |
|
11.7 |
|
|
Patent Term Extensions |
|
|
54 |
|
11.8 |
|
|
Listing of Patents |
|
|
54 |
|
11.9 |
|
|
Trademarks and Copyrights |
|
|
55 |
|
ARTICLE 12 |
|
|
REPRESENTATIONS AND WARRANTIES; EXCLUSIVITY |
|
|
57 |
|
12.1 |
|
|
Representations, Warranties and Covenants |
|
|
57 |
|
12.2 |
|
|
Limitation on Representations or Warranties |
|
|
62 |
|
12.3 |
|
|
Performance by Affiliates |
|
|
62 |
|
12.4 |
|
|
Disclaimer of Warranty |
|
|
62 |
|
12.5 |
|
|
Limitation of Liability |
|
|
62 |
|
12.6 |
|
|
||||






